A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Cai Qingxian
1 trial monitored
See all monitored trials
Liver Cancer
1,602 trials monitored
See 70 trials at risk
Evaluating the effectiveness of standardized HCC risk stratification management in improving early diagnosis rates in patients with chronic liver disease
Trial Details
NCT Number NCT07820644
Lead Sponsor Cai Qingxian
Conditions
(from sponsor)		 Liver Cancer (Primary and Metastatic)
Related terms Liver Neoplasms, Neoplasm Metastasis
Enrollment 15,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov